rss
Occup Environ Med 57:605-614 doi:10.1136/oem.57.9.605
  • Paper

Incidence of lymphohaematopoietic malignancies in a petrochemical industry cohort: 1983–94 follow up

Table 8

Observed/expected, standardised incidence ratios (SIRs) (95% CIs) white and black men by duration of employment for latency category of ⩾40 years

Type of malignancy Latency of ⩾40 y
Duration of employment of <20 y Duration of employment
20–39 y
Duration of employment
⩾40 y
All durations of employment
All malignant neoplasms 0/0.12 377/366.05 89/70.61 466/436.78
1.03 (0.93 to 1.14) 1.268-160 (1.01 to 1.55) 1.07 (0.97 to 1.17)
All lymphohaematopoietic neoplasms8-151 0/0.01 29/22.81 12/4.37 41/27.19
1.27 (0.85 to 1.83) 2.758-150 (1.42 to 4.80) 1.518-150 (1.08 to 2.05)
 Hodgkin's disease 1/0.58 1/0.11 2/0.69
 Non-Hodgkin's lymphoma (SEER) 13/10.22 4/1.93 17/12.15
1.27 (0.68 to 2.18) 1.40 (0.82 to 2.24)
 Multiple myeloma 4/3.93 3/0.81 7/4.74
1.48 (0.59 to 3.04)
 Leukaemia 9/7.73 4/1.45 13/9.18
1.16 (0.53 to 2.21) 1.42 (0.75 to 2.42)
  • 8-150 p<0.05;

  • 8-160 p<0.01.

  • 8-151 Total includes three cases of lymphohaematopoietic malignancy that are not in the categories of lymphoma, leukaemia, or multiple myeloma (see methods text).

This Article

Free sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of OEM.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.